The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Efferocytosis induces macrophage proliferation to help resolve tissue injury
Open accessAbstract
Apoptotic cell clearance by macrophages (efferocytosis) promotes resolution signaling pathways, which can be triggered by molecules derived from the phagolysosomal degradation of apoptotic cells. We show here that nucleotides derived from the hydrolysis of apoptotic cell DNA by phagolysosomal DNase2a activate a DNA-PKcs-mTORC2/Rictor pathway that increases Myc to promote non-inflammatory macrophage proliferation. Efferocytosis-induced proliferation expands the pool of resolving macrophages in vitro and in mice, including zymosan-induced peritonitis, dexamethasone-induced thymocyte apoptosis, and atherosclerosis regression. In the dexamethasone-thymus model, hematopoietic Rictor deletion blocked efferocytosing macrophage proliferation, apoptotic cell clearance, and tissue resolution. In atherosclerosis regression, silencing macrophage Rictor or DNase2a blocked efferocyte proliferation, apoptotic cell clearance, and plaque stabilization. In view of previous work showing that other types of apoptotic cell cargo can promote resolution in individual efferocytosing macrophages, the findings here suggest that signaling-triggered apoptotic cell-derived nucleotides can amplify this benefit by increasing the number of these macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This expands the pool of reparative macrophages, enhancing their capacity for continual apoptotic cell clearance and tissue resolution, and may underlie the sustained reparative capacity exhibited by MerTK+ macrophages (46).”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mechanistically, this approach can harness pathways such as EIMP, which stabilizes a reparative phenotype via the DNase2a-DNA-PKcs-mTORC2-Myc axis (46).”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This aligns with previous research suggesting a role for lipid metabolism in TAM-mediated efferocytosis.”
From Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer (2026) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Complementing this rapid functional rewiring, efferocytosis itself can trigger macrophage proliferation through a defined DNase2a–DNA-PKcs–mTORC2–Myc pathway — a process termed efferocytosis-induced macrophage proliferation (EIMP).”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758
RetractedMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Immunometabolism governs dendritic cell and macrophage function
O'Neill, L. A. J., & Pearce, E. J. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151570 · Cited by 1,779
Jenkins, S. J., Rückerl, D., Cook, P. C., Jackson-Jones, L. H., Finkelman, F. D., van Rooijen, N., MacDonald, A. S., & Allen, J. E. (2011) · Science · doi:10.1126/science.1204351 · Cited by 1,404
Efferocytosis in health and disease
Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066
Self-citationLocal proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041
Cited by
Sorted by citations
Atherosclerosis: Recent developments
Björkegren, J., & Lusis, A. J. (2022) · Cell · doi:10.1016/j.cell.2022.04.004 · Cited by 1,344
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
Drugging the efferocytosis process: concepts and opportunities
Mehrotra, P., & Ravichandran, K. S. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00470-y · Cited by 459
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Macrophage polarization and metabolism in atherosclerosis
Hou, P., Fang, J., Liu, Z., Shi, Y., Agostini, M., Bernassola, F., Bove, P., Candi, E., Rovella, V., Sica, G. S., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06206-z · Cited by 388
Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis
Rodríguez-Morales, P., & Franklin, R. A. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.10.004 · Cited by 341
Hilgendorf, I., Frantz, S., & Frangogiannis, N. G. (2024) · Circulation Research · doi:10.1161/circresaha.124.323658 · Cited by 208
The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation
Schilperoort, M., Ngai, D., Sukka, S. R., Avrampou, K., Shi, H., & Tabas, I. A. (2023) · Immunological Reviews · doi:10.1111/imr.13214 · Cited by 184
Self-citationAmpomah, P. B., Cai, B., Sukka, S. R., Gerlach, B. D., Yurdagul, A., Wang, X., Kuriakose, G., Darville, L. N. F., Sun, Y., Sidoli, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00551-7 · Cited by 180
Self-citationInflammation Resolution: Implications for Atherosclerosis
Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 181
Efferocytosis in atherosclerosis
Adkar, S. S., & Leeper, N. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01037-7 · Cited by 182
PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages
Schilperoort, M., Ngai, D., Katerelos, M., Power, D. A., & Tabas, I. A. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00736-8 · Cited by 166
Self-citationEfferocytosis and Its Role in Inflammatory Disorders
Ge, Y., Huang, M., & Yao, Y.-M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839248 · Cited by 150
Extracellular vesicles arising from apoptosis: forms, functions, and applications
Gregory, C. D., & Rimmer, M. P. (2023) · The Journal of Pathology · doi:10.1002/path.6138 · Cited by 149
Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability
Yurdagul, A. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316233 · Cited by 138
Self-citationGong, S., Zhai, M., Shi, J., Yu, G., Lei, Z., Shi, Y., Zeng, Y., Ju, P., Yang, N., Zhang, Z., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-023-01252-8 · Cited by 129
Self-citationHigh-Dimensional Single-Cell Multimodal Landscape of Human Carotid Atherosclerosis
Bashore, A. C., Yan, H., Xue, C., Zhu, L. Y., Kim, E., Mawson, T. L., Coronel, J., Chung, A. Y., Sachs, N., Ho, S., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320524 · Cited by 123
The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications
Wang, X., Chen, L., Wei, J., Zheng, H., Zhou, N., Xu, X., Deng, X., Liu, T., & Zou, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02220-z · Cited by 132
Self-citationSenescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
Schloesser, D., Lindenthal, L., Sauer, J., Chung, K., Chavakis, T., Griesser, E., Baskaran, P., Maier-Habelsberger, U., Fundel‐Clemens, K., Schlotthauer, I., et al. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202207097 · Cited by 117
Nanomedicine for Diagnosis and Treatment of Atherosclerosis
Cheng, J., Huang, H., Chen, Y., & WU, R. T. (2023) · Advanced Science · doi:10.1002/advs.202304294 · Cited by 119
Macrophages Orchestrate Airway Inflammation, Remodeling, and Resolution in Asthma
Britt, R. D., Ruwanpathirana, A., Ford, M. L., & Lewis, B. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310451 · Cited by 116
He, H., Han, Q., Wang, S., Long, M., Zhang, M., Li, Y., Zhang, Y., & Gu, N. (2023) · ACS Nano · doi:10.1021/acsnano.3c01420 · Cited by 107
Through the layers: how macrophages drive atherosclerosis across the vessel wall
Susser, L. I., & Rayner, K. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157011 · Cited by 112
Ngai, D., Schilperoort, M., & Tabas, I. A. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00921-9 · Cited by 103
Self-citationDiabetic Wound Repair: From Mechanism to Therapeutic Opportunities
Wang, R., Gu, S., Kim, Y. H., Lee, A., Lin, H., & Jiang, D. (2025) · MedComm · doi:10.1002/mco2.70406 · Cited by 118
Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages
Liebold, I., Al Jawazneh, A., Casar, C., Lanzloth, C., Leyk, S., Hamley, M., Wong, M. N., Kylies, D., Gräfe, S. K., Edenhofer, I., et al. (2024) · Science · doi:10.1126/science.abo7027 · Cited by 96
Zhu, Y.-H., Zheng, J.-H., Jia, Q.-Y., Duan, Z., Yao, H., Yang, J., Sun, Y., Jiang, S.-H., Liu, D., & Huo, Y. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00741-1 · Cited by 98
Ji, Y., Li, X., Yao, X., Sun, J., Yi, J., Shen, Y., Chen, B., & Sun, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1732718 · Cited by 101
Giacomini, C., Granéli, C., Hicks, R., & Dazzi, F. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01018-9 · Cited by 98
Chou, M., Babamale, A. O., Walker, T. L., Cognasse, F., Blum, D. L., & Burnouf, T. P. R. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.06.005 · Cited by 84
You, Y., Xu, J., Liu, Y., Li, H., Xie, L., Ma, C., Sun, Y., Tong, S., Liang, K., Zhou, S., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c01497 · Cited by 83
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Sukka, S. R., Ampomah, P. B., Darville, L. N. F., Ngai, D., Wang, X., Kuriakose, G., Xiao, Y., Shi, J., Koomen, J. M., McCusker, R. H., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01115-7 · Cited by 82
Self-citationWang, H., Zhang, Y., Zhang, Y., Li, C., Zhang, M., Wang, J., Zhang, Y., Du, Y., Cui, W., & Chen, W. (2024) · Advanced Materials · doi:10.1002/adma.202402968 · Cited by 82
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Stroope, C., Nettersheim, F. S., Coon, B. G., Finney, A. C., Schwartz, M. A., Ley, K. F., Rom, O., & Yurdagul, A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01015-w · Cited by 74
Self-citationWang, W., Chu, Y., Zhang, P., Liang, Z., Fan, Z., Guo, X., Zhou, G., & Ren, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109790 · Cited by 70
Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression
Cui, K., Gao, X., Wang, B., Wu, H., Kulandaisamy, A., Dong, Y., Xiao, Y., Jiang, X., Malovichko, M. V., Li, K. S., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321723 · Cited by 70
Self-citationMacrophages: a double-edged sword in female reproduction and disorders
Park, M., Kim, Y. S., & Song, H. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01392-6 · Cited by 78
Cardiac macrophages and emerging roles for their metabolism after myocardial infarction
Thorp, E. B. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171953 · Cited by 66
Hamidzada, H., Pascual‐Gil, S., Wu, Q., Kent, G. M., Massé, S., Kantores, C., Kuzmanov, U., Gomez-Garcia, M. J., Rafatian, N., Gorman, R. A., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00471-7 · Cited by 66
Macrophage variants in laboratory research: most are well done, but some are RAW
Herb, M., Schatz, V., Hadrian, K., Hos, D., Holoborodko, B., Jantsch, J., & Brigo, N. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1457323 · Cited by 65
SIRT3 Regulates Clearance of Apoptotic Cardiomyocytes by Deacetylating Frataxin
Gao, J., Huang, C., Kong, L., Zhou, W., Sun, M., Wei, T., & Shen, W. (2023) · Circulation Research · doi:10.1161/circresaha.123.323160 · Cited by 60
Challenges for Clinical Drug Development in Pulmonary Fibrosis
White, E. S., Thomas, M. J., Stowasser, S., & Tetzlaff, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.823085 · Cited by 62
Chen, Z., Li, Z., Huang, H., Shen, G., Ren, Y., Mao, X., Wang, L., Li, Z., Wang, W., Li, G., et al. (2023) · Small · doi:10.1002/smll.202302758 · Cited by 59
Xiong, W., Han, Z., Ding, S., Wang, H., Du, Y., Cui, W., & Zhang, M. (2024) · Advanced Science · doi:10.1002/advs.202400345 · Cited by 57
Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis
Yang, C., Yan-guang, M., Li, S., Zhang, Y., Liu, X., & Li, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1321880 · Cited by 54
Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation
Saas, P., Vetter, M., Maraux, M., Bonnefoy, F., & Perruche, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021413 · Cited by 53
Global Characteristics and Dynamics of Single Immune Cells After Myocardial Infarction
Zhuang, L., Wang, Y., Chen, Z., Li, Z., Wang, Z., Jia, K., Zhao, J., Zhang, H., Xie, H., Lu, L., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027228 · Cited by 52
Qiu, S., Liu, J., Chen, J., Li, Y., Bu, T., Li, Z., Zhang, L., Sun, W., Zhou, T., Hu, W., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02463-y · Cited by 54
Induction of osteoblast apoptosis stimulates macrophage efferocytosis and paradoxical bone formation
Batoon, L., Koh, A. J., Millard, S. M., Grewal, J., Choo, F. M., Kannan, R., Kinnaird, A., Avey, M., Teslya, T., Pettit, A. R., et al. (2024) · Bone Research · doi:10.1038/s41413-024-00341-9 · Cited by 56
Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis
Bonacina, F., Zhang, X., Manel, N., Yvan‐Charvet, L., Razani, B., & Norata, G. D. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01072-4 · Cited by 53
Multifaceted mitochondrial quality control in brown adipose tissue
Aquilano, K., Zhou, B., Brestoff, J. R., & Lettieri‐Barbato, D. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.09.008 · Cited by 50
Bhattacharya, P., Dhawan, U. K., Hussain, M. T., Singh, P., Bhagat, K. K., Singhal, A., Austin‐Williams, S., Sengupta, S., & Subramanian, M. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112808 · Cited by 48
Macrophage heterogeneity and efferocytosis: Beyond the M1/M2 dichotomy
Kumar Jha, P., Aikawa, M., & Aikawa, E. (2024) · Circulation Research · doi:10.1161/circresaha.123.324011 · Cited by 45
Loss of Macrophage mTORC2 Drives Atherosclerosis via FoxO1 and IL-1β Signaling
Zhang, X., Evans, T. D., Chen, S., Sergin, I., Stitham, J., Jeong, S., Rodríguez-Vélez, A., Yeh, Y., Park, A. C., Jung, I., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321542 · Cited by 50
Self-citationJeelani, I., Moon, J.-S., da Cunha, F. F., Nasamran, C. A., Jeon, S., Zhang, X., Bandyopadhyay, G. K., Dobaczewska, K., Mikulski, Z., Hosseini, M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0284 · Cited by 50
Emerging roles of neutrophils in immune homeostasis
Lee, M., Lee, S. Y., & Bae, Y. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.10.115 · Cited by 43
Rapid unleashing of macrophage efferocytic capacity via transcriptional pause release
Tufan, T., Cömertpay, G., Villani, A., Nelson, G. M., Terekhova, M., Kelley, S. M., Zakharov, P. N., Ellison, R. M., Shpynov, O., Raymond, M. H., et al. (2024) · Nature · doi:10.1038/s41586-024-07172-y · Cited by 41
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Self-citationFerroptotic MSCs protect mice against sepsis via promoting macrophage efferocytosis
Pan, Y., Li, J., Wang, J., Jiang, Q., Yang, J., Dou, H., Liang, H., Li, K., & Hou, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05264-z · Cited by 40
Liu, W., Hardaway, B. D., Kim, E., Pauli, J., Wettich, J. L., Yalçınkaya, M., Hsu, C.-C., Xiao, T., Reilly, M. P., Tabas, I. A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci182939 · Cited by 37
Self-citationRetinoic acid signaling in development and differentiation commitment and its regulatory topology
Wu, D., Khan, F. A., Zhang, K., Pandupuspitasari, N. S., Negara, W., Guan, K., Sun, F., & Huang, C. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110773 · Cited by 37
Targeting persistently activated inflammatory microenvironment to promote chronic wound healing
Dai, Y., & Chen, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1708358 · Cited by 44
Zhang, J., Ding, W. B., Zhao, M., Liu, J., Xu, Y., Wan, J., & Wang, M. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15939 · Cited by 38
Yin, Z., Zhang, J., Zhao, M., Liu, J., Xu, Y. Q., Peng, S., Pan, W. D., Wei, C., Zheng, Z., Liu, S., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2367191 · Cited by 35
Impaired Efferocytosis Enables Apoptotic Osteoblasts to Escape Osteoimmune Surveillance During Aging
Xu, R., Xie, H., Shen, X., Huang, J., Zhang, H., Fu, Y., Zhang, P., Guo, S., Wang, D., Li, S., et al. (2023) · Advanced Science · doi:10.1002/advs.202303946 · Cited by 33
Zaid, A. K. M. A., & Ariel, A. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115204 · Cited by 35
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target
Pandit, R., & Yurdagul, A. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01294-y · Cited by 35
Self-citationMechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis
Kumar, D., Pandit, R., & Yurdagul, A. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000017 · Cited by 37
Self-citationRole of Resolvins in Inflammatory and Neuropathic Pain
Park, J., Roh, J., Pan, J., Kim, Y. H., Park, C., & Jo, Y. Y. (2023) · Pharmaceuticals · doi:10.3390/ph16101366 · Cited by 34
Xia, W., Zhu, Z., Xiang, S., & Yang, Y. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.06.006 · Cited by 32
Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies
Xing, J., Wang, K., Xu, Y.-C., Pei, Z.-J., Yu, Q., Liu, X., Dong, Y.-L., Li, S., Chen, Y., Zhao, Y., et al. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103578 · Cited by 31
Cheng, M., Yu, X., Qi, S., Yang, K., Lu, M., Cao, F., & Yu, G. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202407398 · Cited by 33
Hoseinzadeh, A., Esmaeili, S., Sahebi, R., Melak, A. M., Mahmoudi, M., Hasannia, M., & Baharlou, R. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04158-z · Cited by 36
Macrophages in tissue repair and regeneration: insights from zebrafish
Zhao, C., Yang, Z., Li, Y., & Wen, Z. (2024) · Cell Regeneration · doi:10.1186/s13619-024-00195-w · Cited by 31
Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome
Bulnes, J. F., González, L., Velásquez, L., Paz, O. M., Venturelli, P. M., & Martínez, G. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1356023 · Cited by 30
Tsai, T., Zhou, T.-A., Hsieh, Y., Wang, J.-C., Cheng, H.-K., Huang, C., Tsai, P.-Y., Fan, H.-H., Feng, H.-K., Huang, Y. Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111065 · Cited by 29
Liu, Y., Xue, R., Duan, X., Shang, X., Wang, M., Wang, F., Zhu, L., Zhang, L., Ge, X., Zhao, X., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121790 · Cited by 32
Innovative Atherosclerosis Models: Advancing Pathophysiology and Translational Research
Jiang, H., Liao, Y., Zhu, M., Jiramonai, L., Wu, H., Zhong, Y., Xie, Z., & Liang, X. (2025) · Research · doi:10.34133/research.0617 · Cited by 28
Qiang, P., Hao, J., Yang, F., Han, Y., Chang, Y. Y., Xian, Y., Xiong, Y., Gao, X., Liang, L.-J., Shimosawa, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948658 · Cited by 30
Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis
Gregory, C. D. (2023) · Immunological Reviews · doi:10.1111/imr.13259 · Cited by 29
Cell type–specific efferocytosis determines functional plasticity of alveolar macrophages
Better, J., Estiri, M., Wetstein, M., Pervizaj-Oruqaj, L., Malainou, C., Ogungbemi-Alt, V. K., Ferrero, M. R., Langelage, M., Kuznetsova, I., Vazquez‐Armendariz, A. I., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adl3852 · Cited by 32
Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
Ji, W., Zhang, Y., Deng, Y., Li, C., Kankala, R. K., & Chen, A. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad069 · Cited by 28
Immunosenescence and macrophages: From basics to therapeutics
Zhu, H., Shen, F., Liao, T., Qian, H., & Liu, Y. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106479 · Cited by 30
Periodontal Ligament Cell Apoptosis Activates Lepr+ Osteoprogenitors in Orthodontics
Liu, H., Zhang, Y., Zhang, Y., Huang, Y., Yang, Y., Zhao, Y., Chen, S., Deng, J., Li, W., & Han, B. (2024) · Journal of Dental Research · doi:10.1177/00220345241262706 · Cited by 25
Vascular homeostasis in atherosclerosis: A holistic overview
Xu, S., Lyu, Q., Ilyas, I., Tian, X.-Y., & Weng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.976722 · Cited by 26
Chen, J., Wang, Z., Liu, S., Zhao, R., Chen, Q., Li, X., Zhang, S., & Wang, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c11622 · Cited by 27
Kim, S., Kim, Y. K., Kim, S., Choi, Y., Lee, I., Joo, H., Kim, J., Kwon, M., Park, S., Jo, M. K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57133-w · Cited by 25
The formation and consequences of cholesterol-rich deposits in atherosclerotic lesions
Maxfield, F. R., Steinfeld, N., & Ma, C.-I. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1148304 · Cited by 27
Biomimetic “Trojan Horse” Fibers Modulate Innate Immunity Cascades for Nerve Regeneration
Wu, J., Tang, J., Zhang, L., Wang, W., Li, Z., Zhou, L., Jiang, X., Huang, Y., Guo, Q., Wang, W., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c12036 · Cited by 24
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis
He, Z., Luo, Y., Duan, Z., Su, B., Zeng, W., Guo, Y., Li, Y., He, X., Shi, H., Zhou, Z., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.075352 · Cited by 25
Macrophages in Atheromatous Plaque Developmental Stages
von Ehr, A., Bode, C., & Hilgendorf, I. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.865367 · Cited by 24
Li, Y., Lv, J., Liu, S., Wang, Z., Gao, Y., Fan, Z., Huang, L., Cui, J., Zhang, B., Liu, X., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122867 · Cited by 24
Hou, F., Wang, H., Zheng, K., Yang, W., Xiao, K., Rong, Z., Xiao, J., Li, J., Cheng, B., Tang, L., et al. (2023) · Immune Network · doi:10.4110/in.2023.23.e24 · Cited by 23
Tanshinone IIA alleviates atherosclerosis in LDLR−/− mice by regulating efferocytosis of macrophages
Wang, J., Zhang, Y., Feng, X., Du, M., Li, S., Chang, X., & Liu, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1233709 · Cited by 23
A macrophage-collagen fragment axis mediates subcutaneous adipose tissue remodeling in mice
Vujičić, M., Broderick, I., Salmantabar, P., Perian, C., Nilsson, J., Sihlbom, C., & Asterholm, I. W. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2313185121 · Cited by 21
Cellular mechanisms underlying the impairment of macrophage efferocytosis
Ma, Y., Kemp, S. S., Yang, X., Wu, M. H., & Yuan, S. Y. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.02.001 · Cited by 22
Zeng, L., Wang, Y., Huang, Y., Yang, W., Zhou, P., Wan, Y., Tao, K., & Li, R. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02075-5 · Cited by 22
Peng, L., Song, H., Shi, H., Wu, L., Ma, Y., Fan, X., Wu, M., Duan, L., Li, Z., & Yuan, H. (2025) · ACS Nano · doi:10.1021/acsnano.5c10625 · Cited by 24
Wang, Y., Pu, C., Han, Z., Du, Y., Chen, L., Huang, Y., Luo, Y., Xiang, C., He, J., Chen, L., et al. (2025) · Small · doi:10.1002/smll.202405236 · Cited by 23
Wang, H., Gao, Y., Wang, J., Cao, M., Dai, G.-C., Lu, P., Sheng, R., Zhang, C., Wang, Q., Li, G., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c16917 · Cited by 21
Metadata
- Authors
- Gerlach, B. D., Ampomah, P. B., Yurdagul, A., Liu, C., Lauring, M. C., Wang, X., Kasikara, C., Kong, N., Shi, J., Tao, W., & Tabas, I.
- Affiliations
- Columbia University Irving Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Tabas, Ira
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 33
- Issue
- 12
- Pages
- 2445-2463.e8
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC8665147
- OpenAlex
- W3212263362
- Cited by
- 360
- References
- 71
- Citations by year
- 2026: 79 · 2025: 105 · 2024: 91 · 2023: 53 · 2022: 31 · 2021: 1
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 371 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R35 HL145228, K99 HL145131, P20 GM121307, P30CA013696, R01 HL087123, R01 HL127464, S10OD020056, S10RR025686, S10RR027050, T32 5T32HL007343-42)
- American Heart Association (20POST35210962)
- Harvard Medical School (122829)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- efferocytosis, macrophage proliferation, DNA-PKcs, mTORC2, Rictor, c-Myc, atherosclerosis regression, plaque stabilization, peritonitis, thymocyte apoptosis, phagolysosomes
- MeSH terms
- Animals, Macrophages, Mice, Inbred C57BL, Phagocytosis, Apoptosis, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review